smscall
logo
Agriculture

Published On: Feb 9, 2025

Global Bacteriophage Market Outlook and Growth Opportunities 2025

  • starstarstarstarstar
  • 0
  • 0 Reviews
  • 214 Pages
  • 0 Views

Version Type

$4,250.00

Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
According to APO Research, the global Bacteriophage market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Bacteriophage market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Bacteriophage market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and Pherecydes Pharma, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Bacteriophage, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Bacteriophage, also provides the value of main regions and countries. Of the upcoming market potential for Bacteriophage, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bacteriophage revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Bacteriophage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Bacteriophage company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Bacteriophage Segment by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Bacteriophage Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Bacteriophage status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Bacteriophage key companies, revenue, market share, and recent developments.
3. To split the Bacteriophage breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Bacteriophage market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Bacteriophage significant trends, drivers, influence factors in global and regions.
6. To analyze Bacteriophage competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacteriophage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacteriophage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacteriophage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bacteriophage industry.
Chapter 3: Detailed analysis of Bacteriophage company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Bacteriophage in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Bacteriophage in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Table 1:Bacteriophage Industry Trends
Table 2:Bacteriophage Industry Drivers
Table 3:Bacteriophage Industry Opportunities and Challenges
Table 4:Bacteriophage Industry Restraints
Table 5:Global Bacteriophage Revenue by Company (US$ Million) & (2020-2025)
Table 6:Global Bacteriophage Revenue Share by Company (2020-2025)
Table 7:Global Bacteriophage Company Ranking, (2023-2025) & (US$ Million)
Table 8:Global Bacteriophage Key Company Manufacturing Base & Headquarters
Table 9:Global Bacteriophage Company, Product Type & Application
Table 10:Global Bacteriophage Company Establishment Date
Table 11:Global Company Market Concentration Ratio (CR5 and HHI)
Table 12:Global Bacteriophage by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2024)
Table 13:Mergers & Acquisitions, Expansion
Table 14:Significant Companies of DsDNA Bacteriophage
Table 15:Significant Companies of SsDNA Bacteriophage
Table 16:Significant Companies of SsRNA Bacteriophage
Table 17:Significant Companies of Others
Table 18:Global Bacteriophage Sales Value by Type 2020 VS 2024 VS 2031 (US$ Million)
Table 19:Global Bacteriophage Sales Value by Type (2020-2025) & (US$ Million)
Table 20:Global Bacteriophage Sales Value by Type (2026-2031) & (US$ Million)
Table 21:Global Bacteriophage Sales Value Share by Type (2020-2025)
Table 22:Global Bacteriophage Sales Value Share by Type (2026-2031)
Table 23:Significant Companies of Animal Health
Table 24:Significant Companies of Aquaculture
Table 25:Significant Companies of Agriculture
Table 26:Significant Companies of Food Industry
Table 27:Significant Companies of Human Health
Table 28:Significant Companies of Others
Table 29:Global Bacteriophage Sales Value by Application 2020 VS 2024 VS 2031 (US$ Million)
Table 30:Global Bacteriophage Sales Value by Application (2020-2025) & (US$ Million)
Table 31:Global Bacteriophage Sales Value by Application (2026-2031) & (US$ Million)
Table 32:Global Bacteriophage Sales Value Share by Application (2020-2025)
Table 33:Global Bacteriophage Sales Value Share by Application (2026-2031)
Table 34:Global Bacteriophage Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 35:Global Bacteriophage Sales Value by Region (2020-2025) & (US$ Million)
Table 36:Global Bacteriophage Sales Value Share by Region (2020-2025)
Table 37:Global Bacteriophage Sales Value by Region (2026-2031) & (US$ Million)
Table 38:Global Bacteriophage Sales Value Share by Region (2026-2031)
Table 39:Global Bacteriophage Sales Value by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 40:Global Bacteriophage Sales Value by Country (2020-2025) & (US$ Million)
Table 41:Global Bacteriophage Sales Value Market Share by Country (2020-2025)
Table 42:Global Bacteriophage Sales Value by Country (2026-2031) & (US$ Million)
Table 43:Global Bacteriophage Sales Value Market Share by Country (2026-2031)
Table 44:NPO Microgen Company Information
Table 45:NPO Microgen Business Overview
Table 46:NPO Microgen Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47:NPO Microgen Bacteriophage Product Portfolio
Table 48:NPO Microgen Recent Development
Table 49:Proteon Pharmaceuticals Company Information
Table 50:Proteon Pharmaceuticals Business Overview
Table 51:Proteon Pharmaceuticals Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 52:Proteon Pharmaceuticals Bacteriophage Product Portfolio
Table 53:Proteon Pharmaceuticals Recent Development
Table 54:Phagelux Company Information
Table 55:Phagelux Business Overview
Table 56:Phagelux Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 57:Phagelux Bacteriophage Product Portfolio
Table 58:Phagelux Recent Development
Table 59:Intralytix Company Information
Table 60:Intralytix Business Overview
Table 61:Intralytix Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 62:Intralytix Bacteriophage Product Portfolio
Table 63:Intralytix Recent Development
Table 64:Micreos Company Information
Table 65:Micreos Business Overview
Table 66:Micreos Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 67:Micreos Bacteriophage Product Portfolio
Table 68:Micreos Recent Development
Table 69:Eliava BioPreparations Company Information
Table 70:Eliava BioPreparations Business Overview
Table 71:Eliava BioPreparations Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 72:Eliava BioPreparations Bacteriophage Product Portfolio
Table 73:Eliava BioPreparations Recent Development
Table 74:Locus Biosciences,Inc Company Information
Table 75:Locus Biosciences,Inc Business Overview
Table 76:Locus Biosciences,Inc Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 77:Locus Biosciences,Inc Bacteriophage Product Portfolio
Table 78:Locus Biosciences,Inc Recent Development
Table 79:Pharmex Group,LLC Company Information
Table 80:Pharmex Group,LLC Business Overview
Table 81:Pharmex Group,LLC Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 82:Pharmex Group,LLC Bacteriophage Product Portfolio
Table 83:Pharmex Group,LLC Recent Development
Table 84:Pherecydes Pharma Company Information
Table 85:Pherecydes Pharma Business Overview
Table 86:Pherecydes Pharma Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87:Pherecydes Pharma Bacteriophage Product Portfolio
Table 88:Pherecydes Pharma Recent Development
Table 89:APS Biocontrol Ltd. (APS) Company Information
Table 90:APS Biocontrol Ltd. (APS) Business Overview
Table 91:APS Biocontrol Ltd. (APS) Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 92:APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio
Table 93:APS Biocontrol Ltd. (APS) Recent Development
Table 94:Qingdao Phagepharm Bio-tech Company Information
Table 95:Qingdao Phagepharm Bio-tech Business Overview
Table 96:Qingdao Phagepharm Bio-tech Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 97:Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio
Table 98:Qingdao Phagepharm Bio-tech Recent Development
Table 99:Fixed-Phage Limited Company Information
Table 100:Fixed-Phage Limited Business Overview
Table 101:Fixed-Phage Limited Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 102:Fixed-Phage Limited Bacteriophage Product Portfolio
Table 103:Fixed-Phage Limited Recent Development
Table 104:Zeptometrix Company Information
Table 105:Zeptometrix Business Overview
Table 106:Zeptometrix Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 107:Zeptometrix Bacteriophage Product Portfolio
Table 108:Zeptometrix Recent Development
Table 109:Phage International, Inc. Company Information
Table 110:Phage International, Inc. Business Overview
Table 111:Phage International, Inc. Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 112:Phage International, Inc. Bacteriophage Product Portfolio
Table 113:Phage International, Inc. Recent Development
Table 114:MicroMir Company Information
Table 115:MicroMir Business Overview
Table 116:MicroMir Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 117:MicroMir Bacteriophage Product Portfolio
Table 118:MicroMir Recent Development
Table 119:iNtODEWORLD, Inc. Company Information
Table 120:iNtODEWORLD, Inc. Business Overview
Table 121:iNtODEWORLD, Inc. Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 122:iNtODEWORLD, Inc. Bacteriophage Product Portfolio
Table 123:iNtODEWORLD, Inc. Recent Development
Table 124:NEXTBIOTICS Company Information
Table 125:NEXTBIOTICS Business Overview
Table 126:NEXTBIOTICS Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 127:NEXTBIOTICS Bacteriophage Product Portfolio
Table 128:NEXTBIOTICS Recent Development
Table 129:Armata Pharmaceuticals, Inc. Company Information
Table 130:Armata Pharmaceuticals, Inc. Business Overview
Table 131:Armata Pharmaceuticals, Inc. Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 132:Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio
Table 133:Armata Pharmaceuticals, Inc. Recent Development
Table 134:Innophage Company Information
Table 135:Innophage Business Overview
Table 136:Innophage Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 137:Innophage Bacteriophage Product Portfolio
Table 138:Innophage Recent Development
Table 139:Adaptive Phage Therapeutics Company Information
Table 140:Adaptive Phage Therapeutics Business Overview
Table 141:Adaptive Phage Therapeutics Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 142:Adaptive Phage Therapeutics Bacteriophage Product Portfolio
Table 143:Adaptive Phage Therapeutics Recent Development
Table 144:TechnoPhage Company Information
Table 145:TechnoPhage Business Overview
Table 146:TechnoPhage Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025)
Table 147:TechnoPhage Bacteriophage Product Portfolio
Table 148:TechnoPhage Recent Development
Table 149:Research Programs/Design for This Report
Table 150:Authors List of This Report
Table 151:Secondary Sources
Table 152:Primary Sources
Figure 1:Bacteriophage Product Image
Figure 2:Global Bacteriophage Market Size (US$ Million), 2020 VS 2024 VS 2031
Figure 3:Global Bacteriophage Market Size (2020-2031) & (US$ Million)
Figure 4:Global Bacteriophage Company Revenue Ranking in 2024 (US$ Million)
Figure 5:Global Top 5 and 10 Company Market Share by Revenue in 2024 (US$ Million)
Figure 6:Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 7:DsDNA Bacteriophage Image
Figure 8:SsDNA Bacteriophage Image
Figure 9:SsRNA Bacteriophage Image
Figure 10:Others Image
Figure 11:Global Bacteriophage Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12:Global Bacteriophage Sales Value Share 2020 VS 2024 VS 2031
Figure 13:Global Bacteriophage Sales Value Share by Type (2020-2031)
Figure 14:Animal Health Image
Figure 15:Aquaculture Image
Figure 16:Agriculture Image
Figure 17:Food Industry Image
Figure 18:Human Health Image
Figure 19:Others Image
Figure 20:Global Bacteriophage Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21:Global Bacteriophage Sales Value Share 2020 VS 2024 VS 2031
Figure 22:Global Bacteriophage Sales Value Share by Application (2020-2031)
Figure 23:Global Bacteriophage Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24:Global Bacteriophage Sales Value Share by Region: 2020 VS 2024 VS 2031
Figure 25:North America Bacteriophage Sales Value (2020-2031) & (US$ Million)
Figure 26:North America Bacteriophage Sales Value Share by Country (%), 2024 VS 2031
Figure 27:Europe Bacteriophage Sales Value (2020-2031) & (US$ Million)
Figure 28:Europe Bacteriophage Sales Value Share by Country (%), 2024 VS 2031
Figure 29:Asia-Pacific Bacteriophage Sales Value (2020-2031) & (US$ Million)
Figure 30:Asia-Pacific Bacteriophage Sales Value Share by Country (%), 2024 VS 2031
Figure 31:South America Bacteriophage Sales Value (2020-2031) & (US$ Million)
Figure 32:South America Bacteriophage Sales Value Share by Country (%), 2024 VS 2031
Figure 33:Middle East & Africa Bacteriophage Sales Value (2020-2031) & (US$ Million)
Figure 34:Middle East & Africa Bacteriophage Sales Value Share by Country (%), 2024 VS 2031
Figure 35:USA Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 36:USA Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 37:USA Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 38:Canada Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 39:Canada Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 40:Canada Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 41:Mexico Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 42:Mexico Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 43:Mexico Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 44:Germany Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 45:Germany Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 46:Germany Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 47:France Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 48:France Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 49:France Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 50:U.K. Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 51:U.K. Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 52:U.K. Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 53:Italy Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 54:Italy Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 55:Italy Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 56:Spain Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 57:Spain Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 58:Spain Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 59:Russia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 60:Russia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 61:Russia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 62:Netherlands Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 63:Netherlands Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 64:Netherlands Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 65:Nordic Countries Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 66:Nordic Countries Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 67:Nordic Countries Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 68:China Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 69:China Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 70:China Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 71:Japan Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 72:Japan Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 73:Japan Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 74:South Korea Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 75:South Korea Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 76:South Korea Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 77:India Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 78:India Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 79:India Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 80:Australia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 81:Australia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 82:Australia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 83:Southeast Asia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 84:Southeast Asia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 85:Southeast Asia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 86:Brazil Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 87:Brazil Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 88:Brazil Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 89:Argentina Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 90:Argentina Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 91:Argentina Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 92:Chile Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 93:Chile Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 94:Chile Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 95:Colombia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 96:Colombia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 97:Colombia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 98:Peru Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 99:Peru Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 100:Peru Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 101:Saudi Arabia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 102:Saudi Arabia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 103:Saudi Arabia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 104:Israel Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 105:Israel Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 106:Israel Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 107:UAE Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 108:UAE Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 109:UAE Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 110:Turkey Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 111:Turkey Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 112:Turkey Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 113:Iran Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 114:Iran Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 115:Iran Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 116:Egypt Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million)
Figure 117:Egypt Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%)
Figure 118:Egypt Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%)
Figure 119:Years Considered
Figure 120:Research Process
Figure 121:Key Executives Interviewed

Request a Sample

Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Report Cover

Agriculture

Global Bacteriophage Market Outlook and Growth Opportunities 2025

0| 0 Reviews

Pages: 214

Complete Your Request

Select Country
Phone

Customer reviews

  • starstarstarstarstar
  • 0 out of 5
  • 0 Reviews

5

star rating

4

star rating

3

star rating

2

star rating

1

star rating

No Rating Review Exist.

Write Review
  • starstarstarstarstar

Suggested Report

View More

No data found.